Aura Biosciences (AURA) Enterprise Value (2020 - 2026)
Aura Biosciences (AURA) reported Enterprise Value of -$84.8 million for Q1 2026, down 121.82% on a YoY basis from $388.6 million in Q1 2025, and down 42.47% quarter-over-quarter from -$59.5 million in Q4 2025.
Aura Biosciences (AURA) Enterprise Value (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Enterprise Value for 7 years, with the latest figure at -$84.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 121.82% year-over-year to -$84.8 million; the trailing twelve-month figure through Mar 2026 stood at -$84.8 million (down 121.82% YoY), and the FY2025 full-year result was -$59.5 million, down 87.79% from the prior year.
- Enterprise Value for Q1 2026 stood at -$84.8 million, down from -$59.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$19000.0 in Q4 2023, with the low at -$107.4 million in Q2 2025.
- Historically, Enterprise Value has averaged -$32.4 million across 5 years, with a median of -$30.1 million in 2024.
- The largest YoY upside for Enterprise Value was 99.99% in 2022 against a maximum downside of 305450.0% in 2022.
- Aura Biosciences' Enterprise Value stood at -$20000.0 in 2022, then gained by 5.0% to -$19000.0 in 2023, then sank by 166705.26% to -$31.7 million in 2024, then slumped by 87.79% to -$59.5 million in 2025, then sank by 42.47% to -$84.8 million in 2026.
- The last three Enterprise Value figures came in at -$84.8 million (Q1 2026), -$59.5 million (Q4 2025), and -$47.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | -84.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.79 Mn |
| Dec 31, 2025 | -59.52 Mn |
| Sep 30, 2025 | -47.55 Mn |
| Jun 30, 2025 | -107.37 Mn |
| Mar 31, 2025 | -38.23 Mn |
| Dec 31, 2024 | -31.69 Mn |
| Sep 30, 2024 | -25.41 Mn |
| Jun 30, 2024 | -30.08 Mn |
| Mar 31, 2024 | -26.28 Mn |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -20,000.00 |
| Mar 31, 2023 | -38.49 Mn |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | -61.11 Mn |
| Jun 30, 2022 | -28,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -149.06 Mn |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -92.20 Mn |